2-Jul-2026
Arcturus rises on pact with Thermo Fisher for cystic fibrosis therapy
Seeking Alpha News (Thu, 2-Jul 10:15 AM ET)
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
Business Wire (Wed, 1-Jul 8:00 AM ET)
Business Wire (Thu, 28-May 8:00 AM ET)
Thermo Fisher Scientific Announces Quarterly Dividend
Business Wire (Wed, 20-May 5:00 PM ET)
Business Wire (Wed, 20-May 8:30 AM ET)
Business Wire (Thu, 7-May 9:00 AM ET)
Thermo Fisher Scientific to Host Investor Day
Business Wire (Tue, 28-Apr 8:00 AM ET)
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
Business Wire (Mon, 27-Apr 8:00 AM ET)
Thermo Fisher Scientific Reports First Quarter 2026 Results
Business Wire (Thu, 23-Apr 6:00 AM ET)
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
Globe Newswire (Thu, 9-Apr 8:30 AM ET)
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Thermo Fisher Scientific trades on the NYSE stock market under the symbol TMO.
As of July 2, 2026, TMO stock price climbed to $523.44 with 2,157,890 million shares trading.
TMO has a beta of 0.92, meaning it tends to be less sensitive to market movements. TMO has a correlation of 0.10 to the broad based SPY ETF.
TMO has a market cap of $197.47 billion. This is considered a Large Cap stock.
Last quarter Thermo Fisher Scientific reported $11 billion in Revenue and $5.44 earnings per share. This beat revenue expectation by $150 million and exceeded earnings estimates by $.21.
In the last 3 years, TMO traded as high as $643.99 and as low as $385.46.
The top ETF exchange traded funds that TMO belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
TMO has outperformed the market in the last year with a price return of +22.8% while the SPY ETF gained +21.3%. However, in the short term, TMO had mixed performance relative to the market. It has underperformed in the last 3 months, returning +6.6% vs +13.9% return in SPY. But in the last 2 weeks, TMO shares have fared better than the market returning +12.7% compared to SPY -0.3%.
TMO support price is $502.89 and resistance is $523.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMO shares will trade within this expected range on the day.